Vanda Pharmaceuticals | VNDA - Trade Creditors

Stock Price
7.15
Daily Change
0.33 4.77%
Monthly
-13.71%
Yearly
48.54%
Q1 Forecast
6.91

Vanda Pharmaceuticals reported $39.09M in Trade Creditors for its fiscal quarter ending in December of 2024.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Insmed USD 79.91M 316K Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Lexicon Pharmaceuticals USD 3.08M 714K Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 317M 50M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.93B 927M Dec/2025
Takeda JPY 467.59B 28.61B Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024
Veracyte USD 4.59M 916K Dec/2025